Flagg Flanagan is the founder of DiscGenics. DiscGenics has raised $71M in total funding. Latest round: Series C. Based in Salt Lake City, Utah.
Flagg Flanagan is the CEO and Chairman of DiscGenics, a clinical-stage biopharmaceutical company developing regenerative cell-based therapies for degenerative spine diseases. He has led the company through its progression to an FDA-approved Phase 3 program for its lead product, IDCT (rebonuputemcel), aimed at treating degenerative disc disease.
Full founder directory · Investor directory · Company funding database · Fundraising library